scPharmaceuticals is privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. The initial products are based on widely used generic drugs which now require intravenous or intramuscular injections. scPharmaceuticals' innovative products are administered using its proprietary patch pump device based on the revolutionary SenseCore technology, developed by Sensile Medical of Switzerland. This breakthrough delivery system enables a new paradigm of convenient and comfortable anytime anywhere administration of parenteral pharmaceuticals without the need for a healthcare professional to prepare and administer the medication. The scPharmaceuticals antibiotic products aim to avoid the use of PIC (Peripherally-Inserted Central) lines and associated risks, discomfort and costs.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
03/26/14 | $16,000,000 | Series A |
5AM Ventures Lundbeckfond Ventures | undisclosed |
01/04/17 | $45,600,000 | Series B |
5AM Ventures Lundbeckfond Ventures OrbiMed Advisors Sun Pharmaceutical Industries | undisclosed |